We are live on
!
Find out more
SCA
Stonebridge Capital Advisors Portfolio holdings
AUM
$1.43B
1-Year Est. Return
21.98%
This Fund
S&P 500
This Quarter
Est. Return
+2.24%
1 Year Est. Return
+21.98%
3 Year Est. Return
+64.22%
5 Year Est. Return
+80.67%
10 Year Est. Return
+293.7%
AUM
$580M
AUM Growth
+$17.1M
(+3%)
Cap. Flow
+$7.8M
Cap. Flow
% of AUM
1.35%
Top 10 Holdings %
Top 10 Hldgs %
22.47%
Holding
988
New
39
Increased
128
Reduced
204
Closed
80
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CVS Health
CVS
|
+$5.63M |
| 2 |
JWN
Nordstrom
JWN
|
+$4.9M |
| 3 |
UnitedHealth
UNH
|
+$3.55M |
| 4 |
L3Harris
LHX
|
+$1.66M |
| 5 |
IBMM
iShares iBonds Dec 2024 Term Muni Bond ETF
IBMM
|
+$736K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Thermo Fisher Scientific
TMO
|
+$3.37M |
| 2 |
McDonald's
MCD
|
+$2.89M |
| 3 |
CELG
Celgene Corp
CELG
|
+$2.13M |
| 4 |
LLL
L3 Technologies, Inc.
LLL
|
+$1.71M |
| 5 |
IBMH
iShares iBonds Sep 2019 Term Muni Bond ETF
IBMH
|
+$1.55M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 14.57% |
| 2 | Technology | 13.8% |
| 3 | Healthcare | 11.84% |
| 4 | Consumer Staples | 9.36% |
| 5 | Consumer Discretionary | 9.04% |
Similar funds
SMA
ADL
TS
APCM
CCM
KCMH
PPC
SC
Stonebridge Capital Advisors's Q3 2019 Portfolio in Review
As of Q3 2019, Stonebridge Capital Advisors held 988 positions worth $580M, up 3% from $563M the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Stonebridge Capital Advisors's Q3 2019 filing shows 39 new, 128 increased, 204 reduced and 80 closed positions. Its largest new stake was Gladstone Commercial Corp: 5,507 shares worth $129K. The largest sale was Thermo Fisher Scientific, an estimated $3.37M.
By sector, the portfolio is most concentrated in Financials at 15% of assets, down from 15% a quarter earlier, followed by Technology and Healthcare.
- Stonebridge Capital Advisors's largest Q3 2019 buy was Gladstone Commercial Corp: 5,507 shares worth $129K.
- Stonebridge Capital Advisors added most to CVS Health in Q3 2019, an estimated $5.63M increase.
- Stonebridge Capital Advisors's biggest Q3 2019 reduction was Thermo Fisher Scientific, cutting an estimated $3.37M.
- Stonebridge Capital Advisors fully exited L3 Technologies, Inc. in Q3 2019, selling an estimated $1.71M.
- Stonebridge Capital Advisors's ten largest holdings make up 22% of its $580M portfolio in Q3 2019.
- Stonebridge Capital Advisors opened 39 new positions and closed 80 in Q3 2019.
- Stonebridge Capital Advisors's portfolio value rose 3% quarter-over-quarter to $580M.
Based on Stonebridge Capital Advisors's 13F filing for Q3 2019, filed 12 Nov 2019.